Where I see patients (1)
Venetoclax and dinaciclib elicit synergistic preclinical efficacy against hypodiploid acute lymphoblastic leukemia.
Venetoclax in combination with chemotherapy as treatment for pediatric advanced hematologic malignancies.
Pediatric blood & cancer
Nf1 and Sh2b3 mutations cooperate in vivo in a mouse model of juvenile myelomonocytic leukemia.
Tender wagging care